global strategi innov solut lead doubl digit growth
maintain buy rate cigna corp
maintain tp deriv tp base
forward price-to-earnings adjust ep
provid upsid potenti
expect top-lin revenu grow
estim base follow factor double-digit
growth revenu earn strong growth across
busi segment acquisit express script
deliv double-digit growth revenu
earn due growth across busi segment total
revenu increas global
health care medic cost increas
due custom growth commerci segment
medic cost trend
adjust incom oper increas
due impact lower tax rate effect
januari non-gaap ep increas
due continu strong contribut
cigna corpor express script announc doj
clear pend merger termin applic
wait period hart-scott-rodino anti-trust
improv act
global health revenu increas
due commerci custom growth expans
specialti relationship also due premium growth
reflect return health insur tax underli
compani name corporationtickercistock ratingbuyunchangedindustri viewoverweightpositivepric oct week week volum volum ep margin margin ttm per share growth profit ttm ttm incom ttm earn growth corporation| octob
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
end global medic
custom organ increas live year-to-
date led growth select middl market individu
total commerci medic care ratio
reflect on-going strong perform commerci
busi power integr medic solut better-
than-expect result individu busi
price effect resumpt health insur
tax total govern mcr reflect
solid execut medicar advantag part
grew earn increas
group disabl life busi earn
grew quarter
expect revenu grow adjust
net incom oper expect
non-gaap ep expect
per share
current price-to-earnings averag price-to-earnings
due huge fluctuat stock price past
year price-to-earnings trade near
price-to-earnings trade
due increas stock price expect
forward price-to-earnings
recommend buy rate stock tp
base perform
acquisit express script
stock price histori date high obsolet date obsolet move move share statist averag volum averag volum share held held share short short share short prior month error dividend split forward annual dividend forward annual dividend trail annual dividend trail annual dividend year averag dividend pay-out dividend date apr ex-dividend date last split factor new per last split date jun inform cigna corporation| octob
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
non- reconcili refer page
incom statement item total total benefit claim gross oper incom incom incom tax expens net net incom avail common earn per averag share annual actual annual actual quarterli corporation| octob
loan short-term cash premium defer polici acquisit defer incom tax properti separ account total futur polici policyhold unearn short-term long-term separ account total common addit paid-in retain treasuri accumul comprehens total stockhold liabil total liabil stockhold balanc sheet itemsactu annual actual quarterli corporation| octob
flow oper activ increas compar
due higher net incom
use invest activ compar due higher net
use financ activ compar due lower
stock repurchas repay long-term debt partial off-set bridg financ fee paid
gain equiti incom loss equiti method depreci defer tax benefit reserv claim claim adjust capit defer polici acquisit asset oper net cash provid oper sales/matur fix matur equiti acquisit purchas loan properti equip invest net cash use invest chang short-term long-term debt long-term debt common stock repurchas treasuri financ net cash provid use financ effect exchang rate net chang begin end paid incom paid corporation| octob
cigna corpor deliv strong quarterli result due continu strong
busi growth global global supplement
total revenu increas compar
increas due continu strong busi growth
cigna global health global supplement benefit segment
premium increas compar
premium increas due custom growth commerci
segment includ contribut specialti product well growth
global supplement benefit segment increas also due higher
rate commerci segment reflect underli medic cost trend
govern suspens cost share reduct subsidi
resumpt health insur industri tax
fee increas compar
due growth specialti busi increas custom
base administr servic busi aso
net invest incom increas compar
due growth averag asset higher yield due
increas partnership incom revenu
compar
mail order pharmaci revenu rel flat
net realiz invest loss compar net realiz
invest gain declin due lower gain
sale altern partnership fix matur invest well mark-
to-market loss equiti secur report net incom
global health care medic cost increas
compar due custom growth commerci
segment medic cost trend
compar
compar
due
custom growth
commerci segment
medic cost trend
benefit expens increas compar
due custom growth global supplement benefit
segment mail order pharmaci cost declin
compar
increas
compar
total oper expens increas compar
due resumpt health insur industri
tax volume-bas expens reflect busi growth spend
busi initi increas transaction-rel cost
increas
compar
due continu
growth
total depreci amort declin
compar interest expens declin
compar special item increas
compar total benefit expens increas
compar
effect tax rate decreas compar
due lower tax rate effect sinc januari
sharehold net incom decreas compar
due increas after-tax transact cost report
special item lower realiz invest result off-set higher adjust
incom oper
adjust incom oper increas
compar due impact lower tax rate
effect januari custom growth global
global supplement benefit segment togeth increas contribut
specialti product commerci segment also contribut
increas incom oper
ep increas compar
non-gaap ep increas compar
due continu strong contribut
premium increas
compar
due
custom growth
commerci segment
specialti product
well growth
total revenu increas compar
increas due continu strong busi growth cigna
global health global supplement benefit segment
premium increas compar
due custom growth commerci segment includ
contribut specialti product well growth global
fee increas compar net
invest incom increas compar
mail order pharmaci revenu increas
compar revenu decreas
compar
net realiz invest loss compar net realiz
invest gain declin due lower gain
sale altern partnership fix matur invest well mark-
to-market loss equiti secur report net incom
global health medic cost increas
compar due custom growth commerci
segment medic cost trend
benefit expens increas compar
mail order pharmaci cost declin
compar
oper expens increas compar
due resumpt health insur industri tax
volume-bas expens reflect busi growth spend busi
initi increas transaction-rel cost absenc long-
term care guaranti fund assess recogn partial off-set
total depreci amort expens declin
compar interest expens declin
compar special item decreas
compar total benefit
expens increas compar
effect tax rate declin compar
sharehold incom increas
compar adjust incom oper increas
compar due
continu strong contribut growth platform
gaap ep increas compar
non-gaap ep increas compar
market invest june august
repurchas share common stock
expect conduct addit share repurchas prior close
adjust incom
oper increas
compar
due
continu strong
contribut
gaap ep increas
compar
increas
compar
report segment consist global health care global supplement
benefit group disabl life corpor oper
global health care
segment increas
compar
total oper revenu global health care segment increas
compar total
oper revenu increas compar
increas due custom growth
commerci busi premium increas consist underli cost
trend expans specialti relationship
total premium global health care segment increas
compar total premium
increas compar
total fee increas compar
total fee increas compar
mail order pharmaci revenu
oper
increas
compar
adjust incom oper increas
compar adjust net margin
increas compar growth
reflect medic specialti busi growth strong medic cost
perform lower tax rate favor prior year reserv
develop prior year reserv develop
after-tax basi respect
total medic custom increas custom
compar custom due continu
organ growth select middl market individu segment
total commerci custom increas custom
compar custom total
commerci medic care ratio reflect consist
strong perform commerci employ busi favor
individu price effect resumpt health insur tax
favor prior year reserv develop
total govern custom decreas custom
compar custom total govern medic
care ratio reflect solid execut medicar
advantag part
total custom behavior increas
compar total custom dental increas
compar total custom
pharmaci decreas compar
total custom medicar part decreas custom
compar custom
global oper expens ratio reflect
return health insur tax on-going invest growth
innov continu effect expens manag global
health net medic cost payabl
total oper revenu global supplement benefit increas
compar total
oper revenu increas compar
revenu growth due busi growth
unit state south korea favor impact foreign
currenc movement primarili south korean
total premium increas compar
total premium increas
compar total polici increas
compar
adjust incom oper increas
compar adjust margin declin
compar adjust incom
oper increas compar
increas due busi growth primarili south
korea china lower acquisit cost oper expens ratio
expens ratio
reflect return
on-going invest
growth innov
continu effect
global
increas
compar
global supplement benefit segment loss ratio increas
compar increas due shift
busi mix higher loss ratio product loss ratio
declin compar due favor claim
experi south korea partial off-set shift busi mix
acquisit cost ratio decreas compar
due shift toward higher premium product lower
acquisit cost primarili unit state
oper expens ratio exclud acquisit cost decreas
compar reflect strong expens
group disabl life segment
total oper revenu group disabl life segment
increas compar
total oper revenu rel flat
revenu slightli higher due moder busi growth higher
total premium increas compar
total premium rel flat total fee
flat
adjust incom oper increas
compar adjust incom oper
increas compar
increas due lower tax rate favor life result
partial off-set less favor disabl result
segment loss ratio decreas compar
due lower life new claim incid partial off-set
group disabl
life segment
increas
compar
adjust incom
oper increas
compar
group disabl life segment
oper expens ratio increas compar
due higher commiss rate premium tax
corpor oper
corpor
revenu increas
compar
corpor segment oper revenu increas
compar total oper
revenu
corpor adjust loss oper increas
compar due lower tax benefit includ lower
excess tax benefit stock compens impact lower
tax rate effect result tax reform legisl
oper
expect
adjust net incom oper
adjust incom oper
group disabl life
corpor oper
oper metric ratio outlook
custom
outlook exclud impact addit prior year reserv
develop potenti effect futur capit deploy
outlook consolid adjust incom oper
rang non-gaap ep expect
total revenu growth expect adjust tax rate
expect rang
commerci medic care ratio expect rang
govern medic ratio expect rang
global health oper expens ratio expect rang
global medic custom growth expect
total revenu growth
expect
adjust tax
rate expect
rang
growth expect
deliv strong oper result double-digit revenu
growth earn growth continu industry-lead medic cost
trend consolid revenu increas adjust ep
increas quarter
global revenu increas drive earn
growth strong contribut commerci
revenu grew earn increas
group disabl life busi earn grew
expand diabet prevent program dpp collabor
omada health new program design deliv expand suit
person user-friendli digit health tool help peopl prevent onset
diabet chronic diseas avail nation
region employ client effect januari
cigna corpor express script hold compani announc
anti-trust divis unit state depart justic doj clear
pend merger termin applic wait period
hart-scott-rodino anti-trust improv act
script share goal ensur custom highest level access
right medic therapi clinic coordin fashion
announc launch ventur corpor ventur fund
focus transform innov health care compani
commit capit cigna ventur invest promis startup
growth-stag compani unlock new growth possibl
health care bring improv care qualiti afford choic greater
simplic custom client cigna ventur focus compani
across three strateg area insight analyt digit health retail
ytd stock perform compar
roa roe ttm basi respect
double-digit
earn growth
cigna corpor
doj clear
pend merger
non- reconcili
non- reconcili
non- reconcili
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
revenu growth ttm compar
tax rate reduc ttm compar
ep ttm compar
net margin increas ttm compar
ratio revenu margin margin inc margin rate margin turnov averag asset leverag averag equiti year averag averag averag year averag averag averag year averag averag averag growth growth ex sale /sale /net incom ratio profit marginsprofitabilityrevenu growth oper incom growthep growth corporation| octob
invest flow
sale
mrqyoy growth revenu growthoper incom growthep mrq ratio growth yoy oper growth yoy free growth mrqcapex salescap ex salesfre mrqfinanci mrqreturn mrqreturn asset cigna corporation| octob
per share item ratio
fiscal per ebitda per share- ebit per share- earn per share ep ep free cash-flow per dividend per book valu per tangibl book per month end stock month end stock equiti return asset return invest capit return capit joel greenblatt errorerrorerrorerrorerrorerrorerrorerrorerrorerrordebt gross margin errorerrorerrorerrorerrorerrorerrorerrorerrorerroroper margin net margin total equiti total lt debt total asset dividend pay-out day sale outstandingerrorerrorerrorerrorerrorerrorerrorerrorerrorerrorday account payableerrorerrorerrorerrorerrorerrorerrorerrorerrorerrorday inventoryerrorerrorerrorerrorerrorerrorerrorerrorerrorerrorcash convers cycleerrorerrorerrorerrorerrorerrorerrorerrorerrorerrorinventori turnovererrorerrorerrorerrorerrorerrorerrorerrorerrorerrorcog revenueerrorerrorerrorerrorerrorerrorerrorerrorerrorerrorinventori revenueerrorerrorerrorerrorerrorerrorerrorerrorerrorerrortax rate net incom net incom discontinued- net net margin prefer dividends- annual itemsquarterli item cigna corporation| octob
outstand equival market securitieserrorerrorerrorerrorerrorerrorerrorerrorerrorerrordebt common prefer stock- purchas properti plant sale properti plant equipment- purchas business- sale business- purchas sale issuanc repurchas net issuanc prefer stock- net issuanc net chang capit free corporation| octob
current price-to-earnings averag price-to-earnings due huge fluctuat stock price
past price-to-earnings trade near price-to-earnings trade
due increas stock price expect forward price-to-earnings
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
breakdown share held share held float held institut hold top institut holdersholdershar report outvaluepric row associ vanguard group inc dodg cox fmr wellington manag compani jp morgan massachusett servic tiaa-cref invest manag top mutual fund holdersholdersharesd report outvaluedodg cox stock vanguard specialized-health vanguard total stock market vanguard spdr etf vanguard institut fund-institut price row growth stock fund price row chip growth fund colleg retir equiti fund-stock price row institut larg cap growth corporation| octob
develop expand person diabet prevent program collabor omada expand diabet prevent program dpp collabor omada health new program design deliv expand suit person user-friendli digit health tool help peopl prevent onset diabet chronic diseas avail nation region employ client effect januari depart justic grant clearanc acquisit script corporationand script hold compani announc anti-trust divis unit state depart justic doj clear pend merger termin applic wait period hart-scott-rodino anti-trust improv act announc ventur million fund transm innov growth care announc launch ventur corpor ventur fund focus transform innov health care compani commit capit ventur invest promis startup growth-stag compani unlock new growth possibl health care bring improv care qualiti afford choic greater simplic custom client ventur focus compani across three strateg area insight analyt digit health retail care delivery/manag corpor announc price billion senior note corpor announc halfmoon parent inc issuer direct wholli own subsidiari price offer offer aggreg princip amount senior float rate note due interest rate equal three-month libor plu per annum aggreg princip amount senior note due aggreg princip amount senior float rate note due interest rate equal three-month libor plu per annum aggreg princip amount senior note due aggreg princip amount senior float rate note due interest rate equal three-month libor plu per annum aggreg princip amount senior note due aggreg princip amount senior note due aggreg princip amount senior note due aggreg princip amount senior note due aggreg princip amount senior note due corporation| octob
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
compar
roa roe
ttm basi
actual vs price-to-earnings ratio ttm price-to-earnings high last yr price-to-earnings last yr beta price sale ttm price book mrq price ttm price free ttm errorerrorerror own dividend yield dividend yield year average dividend year growth rate pay-out ratio ttm sale mrq vs qtr yr sale ttm vs ttm yr sale yr growth rate sale yr growth rate ep mrq vs qtr yr ep ttm vs ttm yr ep yr growth rate ep yr growth rate capit spend yr growth rate lt debt equiti mrq total debt equiti mrq interest coverag ttm gross margin ttm gross margin yr average ebitd margin ttm ebitd yr average oper margin ttm oper margin yr average pre-tax margin ttm pre-tax margin yr average net profit margin ttm net profit margin yr average effect tax rate ttm effect tax rate yr average return asset ttm return asset yr average return invest ttm return invest yr average return equiti ttm return equiti yr average revenue/employe ttm net income/employe ttm receiv turnov ttm inventori turnov ttm asset turnov ttm manag effect effici performancevalu ratio dividend growth rate ratio profit corporation| octob
consensu view analyst trend stock
forecast
forward price-to-earnings ratio
expect
rel lower
ci avgfive-year growth forecast usdgrowth high day day day estim comparisonciindustri avg avgprice/earn yield corporation| octob
consensu view analyst trend stock
averag earn estim
current qtr
next qtr
sale growth estim current
qtr next
qtr
averag revenu estim
current qtr
estimatescurr analyst estimatethi estim estimatepast ep growthprice/earningsobsoleteobsoleteobsoleteobsoletepeg ratioobsoleteobsoleteobsoleteobsoleteconsensu ep day day day day ep revisionsn/an/an/an/aup last daysn/an/an/an/aup last daysn/an/an/an/adown last dayserrorerrorerrorerrordown last dayscurr surprisescurr growth rate analyst recommend
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
stock price show upward trend quarter surg doj grant
clearanc acquisit express script
stock averag trade volum given return
stock show huge fluctuat gave return last one year rang
stock price surg januari declin march due
acquisit announc express script
stock shown huge fluctuat past given return past
stock dip march due acquisit announc express script
stock volatil till later show upward trend
deliv strong perform quarter due growth across global health
global supplement benefit group disabl life busi recommend buy rate
stock tp expect revenu grow base
perform acquisit express script
crispidea financi inform servic firm focus provid equiti research portfolio manag
person wealth manag brokerag servic inform servic side provid commun
consult research servic host client
crispidea track limit number compani sector strive provid qualiti insight straight
forward analysi object creat long-term wealth moder low risk crispidea leverag
larg number in-hous extern expert oper within industri strong financi oper
strateg background
detail visit www crispidea com contact
